Status:
COMPLETED
Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and Psoriasis
Lead Sponsor:
Bioiberica
Conditions:
Osteoarthritis
Psoriasis
Eligibility:
All Genders
40+ years
Phase:
PHASE4
Brief Summary
The purpouse of this study is to determine the efficacy and safety of chondroitin sulphate conventional treatment in patients with both knee osteoarthritis and plaque psoriasis.
Eligibility Criteria
Inclusion
- Primary knee OA according to ACR criteria;
- OA of radiological stages 1 to 3 according to Kellgren-Lawrence;
- VAS of pain ≥30;
- PASI ≥ 5.
Exclusion
- Known allergy to chondroitin sulphate;
- Other bone and articular diseases such as chondrocalcinosis, Paget's disease, rheumatoid arthritis, psoriatic arthritis, acromegaly, hemochromatosis, Wilson's disease;
- Patients with skin conditions that could interfere in the clinical trial evaluation
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT00669123
Last Update
April 29 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital del Mar
Barcelona, Barcelona, Spain, 08003
2
Instituto Poal de Reumatología
Barcelona, Barcelona, Spain, 08022